Topline data were announced from a phase 3 trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity.

Glucagon-like peptide 1 receptor agonist therapy over a 12-month period is safe and effective in treating weight regain ...

Nearly all U.S. adults with obesity as diagnosed by BMI also have an elevated waist circumference or excess body fat, ...

High schools have long been recognized for shaping students' futures. According to a new study by researchers from Penn State ...

There has previously been speculation that Trump may have lose some weight during his campaign. Now, thanks to Trump's annual ...

A STUDENT nurse is one step closer to her dream of having a baby after shedding 115lbs on Mounjaro. Laurie Murray, from Airdrie, started using the weight loss jabs last April when she tipped the ...

Snacking between meals can spoil your appetite for a proper meal but there is one supplement to help calibrate your body ...

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

FRIDAY, April 18, 2025 (HealthDay News) -- Complications during pregnancy can mean a woman’s future heart health is at risk, particularly if she is overweight or obese, a new study says.

When you're hungry, ghrelin hormone levels increase in your stomach and other parts of your body. Learn what causes its ...

The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and ...